S&N spins off its Biologics arm into a Private Equity JV called Bioventus

 
 
SNN spins out biologics unit in JV with Essex Woodlands (Mass Device)
Orthopedics giant Smith & Nephew shuffles its divisions again with the spinout of its biologics and clinical therapies division in a joint venture with Houston's Essex Woodlands venture capital shop.
British orthopedic titan Smith & Nephew (NYSE:SNN) shuffled its business deck yet again with the spinout of its biologics and clinical therapies division in a joint venture with venture capital firm Essex Woodlands.
Essex will own 51% of the new business, named Bioventus LLC, with Smith & Nephew holdin...